Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T00:17:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; there is no visible impact on study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:23:50.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, a minor UI/version update with no changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:10:47.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page, and several textual updates were made, including capitalizing 'Last Update Submitted that Met QC Criteria' and updating the label to 'No FEAR Act Data' with the revision now listed as v3.4.0. The previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:32:00.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, or results are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:57.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.